Valneva (VALN) News Today $7.05 0.00 (0.00%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$7.00 -0.04 (-0.64%) As of 04/15/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period 1VALN : 12 Analysts Assess Valneva: What You Need To KnowApril 15 at 4:27 PM | benzinga.comValneva shares leap on Brazilian approval of chikungunya vaccineApril 14 at 8:26 PM | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 14 at 5:45 PM | prnewswire.comMajor West Lothian employer invests in its emerging leadersApril 14 at 3:26 PM | msn.comBrazil Approves Valneva's Mosquito-Borne Chikungunya VaccineApril 14 at 2:28 PM | benzinga.comValneva’s Chikungunya Vaccine Gains First Approval in BrazilApril 14 at 2:22 PM | tipranks.comValneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic CountryApril 14 at 11:45 AM | globenewswire.comMajor Livingston employer invests in its emerging leadersApril 14 at 10:25 AM | msn.comValneva (NASDAQ:VALN) Sees Strong Trading Volume - Here's What HappenedValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - What's Next?April 11, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Valneva (NASDAQ:VALN)HC Wainwright reissued a "buy" rating and issued a $17.00 target price on shares of Valneva in a research report on Wednesday.April 11, 2025 | marketbeat.comValneva (NASDAQ:VALN) Trading Up 6.2% - Here's WhyValneva (NASDAQ:VALN) Stock Price Up 6.2% - What's Next?April 9, 2025 | marketbeat.comValneva and LimmaTech Initiate Phase 2 Study of Shigella VaccineApril 9, 2025 | tipranks.comValneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2April 9, 2025 | globenewswire.comValneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2April 9, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 8, 2025 | prnewswire.comReviewing Valneva (NASDAQ:VALN) and Organovo (NASDAQ:ONVO)April 8, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNApril 7, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 7, 2025 | globenewswire.comVALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law FirmApril 7, 2025 | prnewswire.comVALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law FirmApril 4, 2025 | businesswire.comValneva SE Shareholding Declaration - March 2025April 3, 2025 | finance.yahoo.comValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedApril 2, 2025 | marketbeat.comValneva granted EC marketing authorization for Ixchiq vaccineApril 2, 2025 | markets.businessinsider.comValneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and AboveApril 2, 2025 | markets.businessinsider.comIs Valneva (VALN) the Best Performing NASDAQ Stock So Far in 2025?April 2, 2025 | msn.comValneva’s Chikungunya Vaccine Gains EU Approval for AdolescentsApril 1, 2025 | tipranks.comValneva (NASDAQ:VALN) Shares Gap Down - What's Next?Valneva (NASDAQ:VALN) Shares Gap Down - Here's What HappenedApril 1, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Valneva (NASDAQ:VALN)HC Wainwright reiterated a "buy" rating and issued a $17.00 target price on shares of Valneva in a research report on Monday.April 1, 2025 | marketbeat.comValneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and AboveApril 1, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 31, 2025 | prnewswire.comValneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRAMarch 31, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 30, 2025 | globenewswire.comValneva renews sales agreement in connection with existing at-the-market programMarch 27, 2025 | markets.businessinsider.comValneva SE (NASDAQ:VALN) Sees Significant Increase in Short InterestValneva SE (NASDAQ:VALN - Get Free Report) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 16,900 shares, a growth of 191.4% from the February 28th total of 5,800 shares. Based on an average daily volume of 57,400 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the shares of the company are short sold.March 27, 2025 | marketbeat.comValneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) ProgramMarch 26, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Down Following Analyst DowngradeValneva (NASDAQ:VALN) Shares Gap Down Following Analyst DowngradeMarch 26, 2025 | marketbeat.comValneva files prospectus for sale of up to $350M sharesMarch 26, 2025 | markets.businessinsider.comValneva (VALN) Receives a Buy from H.C. WainwrightMarch 25, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 25, 2025 | prnewswire.comGuggenheim Lowers Valneva (NASDAQ:VALN) Price Target to $15.00Guggenheim lowered their price target on shares of Valneva from $17.00 to $15.00 and set a "buy" rating for the company in a report on Monday.March 25, 2025 | marketbeat.comValneva Announces Filing of 2024 Universal Registration Document and US Form 20-FMarch 25, 2025 | globenewswire.comValneva outlays 40,000 vaccines to Réunion amidst chikungunya surgeMarch 24, 2025 | finance.yahoo.comValneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La RéunionMarch 24, 2025 | markets.businessinsider.comValneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La RéunionMarch 24, 2025 | globenewswire.comValneva (NASDAQ:VALN) Stock Price Up 2.3% - Should You Buy?Valneva (NASDAQ:VALN) Shares Up 2.3% - Here's WhyMarch 22, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Valneva (NASDAQ:VALN)HC Wainwright reiterated a "buy" rating and set a $17.00 price objective on shares of Valneva in a research report on Friday.March 22, 2025 | marketbeat.comValneva’s Earnings Call Highlights Robust Growth Amid ChallengesMarch 22, 2025 | msn.comValneva outlines €170M-€180M sales target for 2025 with focus on IXCHIQ and Lyme vaccine developmentsMarch 21, 2025 | msn.com3VALN : Breaking Down Valneva: 6 Analysts Share Their ViewsMarch 21, 2025 | benzinga.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?Valneva (NASDAQ:VALN) Shares Gap Up - Time to Buy?March 21, 2025 | marketbeat.com Remove Ads Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.280.79▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼184▲VALN Articles Average Week Remove Ads Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News VCEL News BHC News BHVN News TARS News AAPG News BLTE News NAMS News MTSR News ARQT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VALN Stock Free VALN Stock Alerts